In the October 6, 2015, Federal Register, FDA announced that it would reopen the comment period for the draft guidance published on June 1, 2015 titled "Established Conditions: Reportable Chemistry, Manufacturing, and Controls ("CMC") Changes for Approved Drug and Biologic Products; Draft Guidance for Industry." Comments now due January 4, 2015.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
